Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry ; volume:16 ; number:1 ; day:1 ; month:4 ; year:2023 ; pages:1-5 ; date:12.2023
Journal of hematology & oncology ; 16, Heft 1 (1.4.2023), 1-5, 12.2023
- Urheber
-
Marchesi, Francesco
Salmanton-García, Jon
Buquicchio, Caterina
Itri, Federico
Besson, Caroline
Dávila-Valls, Julio
Martín-Pérez, Sonia
Fianchi, Luana
Rahimli, Laman
Tarantini, Giuseppe
Grifoni, Federica Irene
Sciume, Mariarita
Labrador, Jorge
Cordoba, Raul
López-García, Alberto
Fracchiolla, Nicola S.
Farina, Francesca
Ammatuna, Emanuele
Cingolani, Antonella
García-Bordallo, Daniel
Gräfe, Stefanie K.
Bilgin, Yavuz M.
Dargenio, Michelina
González-López, Tomás José
Guidetti, Anna
Lahmer, Tobias
Lavilla-Rubira, Esperanza
Méndez, Gustavo-Adolfo
Prezioso, Lucia
Schönlein, Martin
Van Doesum, Jaap
Wolf, Dominik
Hersby, Ditte Stampe
Magyari, Ferenc
Van Praet, Jens
Petzer, Verena
Tascini, Carlo
Falces-Romero, Iker
Glenthøj, Andreas
Cornely, Oliver Andreas
Pagano, Livio
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13045-023-01423-7
- URN
-
urn:nbn:de:101:1-2023081721023144919103
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Marchesi, Francesco
- Salmanton-García, Jon
- Buquicchio, Caterina
- Itri, Federico
- Besson, Caroline
- Dávila-Valls, Julio
- Martín-Pérez, Sonia
- Fianchi, Luana
- Rahimli, Laman
- Tarantini, Giuseppe
- Grifoni, Federica Irene
- Sciume, Mariarita
- Labrador, Jorge
- Cordoba, Raul
- López-García, Alberto
- Fracchiolla, Nicola S.
- Farina, Francesca
- Ammatuna, Emanuele
- Cingolani, Antonella
- García-Bordallo, Daniel
- Gräfe, Stefanie K.
- Bilgin, Yavuz M.
- Dargenio, Michelina
- González-López, Tomás José
- Guidetti, Anna
- Lahmer, Tobias
- Lavilla-Rubira, Esperanza
- Méndez, Gustavo-Adolfo
- Prezioso, Lucia
- Schönlein, Martin
- Van Doesum, Jaap
- Wolf, Dominik
- Hersby, Ditte Stampe
- Magyari, Ferenc
- Van Praet, Jens
- Petzer, Verena
- Tascini, Carlo
- Falces-Romero, Iker
- Glenthøj, Andreas
- Cornely, Oliver Andreas
- Pagano, Livio
- SpringerLink (Online service)
Ähnliche Objekte (12)
The role of BCL11B in hematological malignancy
Immunogenic Cell Death in Hematological Malignancy Therapy
Chryseobacterium indologenes: An emerging uropathogen among hematological malignancy patients
Management strategy for hematological malignancy patients with acute respiratory failure
Differentiating central nervous system infection from disease infiltration in hematological malignancy
Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan
A Rare Occurrence of Solid Gynecological Malignancy Synchronous with Hematological Malignancy: Rare Case and Review of Literature
Pediatric hematological malignancy: Identification of issues involved in the road to diagnosis
Germline ERG haploinsufficiency defines a new syndrome with cytopenia and hematological malignancy predisposition
Author Correction: Differentiating central nervous system infection from disease infiltration in hematological malignancy
Targeting TIM-3 for hematological malignancy: latest updates from the 2022 ASH annual meeting
Cryoglobulinemia as an Initial Manifestation of Underlying Hematological Malignancy: A Rare Occurrence in India
The role of BCL11B in hematological malignancy
Immunogenic Cell Death in Hematological Malignancy Therapy
Chryseobacterium indologenes: An emerging uropathogen among hematological malignancy patients
Management strategy for hematological malignancy patients with acute respiratory failure
Differentiating central nervous system infection from disease infiltration in hematological malignancy
Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan
A Rare Occurrence of Solid Gynecological Malignancy Synchronous with Hematological Malignancy: Rare Case and Review of Literature
Pediatric hematological malignancy: Identification of issues involved in the road to diagnosis
Germline ERG haploinsufficiency defines a new syndrome with cytopenia and hematological malignancy predisposition
Author Correction: Differentiating central nervous system infection from disease infiltration in hematological malignancy
Targeting TIM-3 for hematological malignancy: latest updates from the 2022 ASH annual meeting
Cryoglobulinemia as an Initial Manifestation of Underlying Hematological Malignancy: A Rare Occurrence in India
The role of BCL11B in hematological malignancy
Immunogenic Cell Death in Hematological Malignancy Therapy
Chryseobacterium indologenes: An emerging uropathogen among hematological malignancy patients
Management strategy for hematological malignancy patients with acute respiratory failure
Differentiating central nervous system infection from disease infiltration in hematological malignancy
Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan
A Rare Occurrence of Solid Gynecological Malignancy Synchronous with Hematological Malignancy: Rare Case and Review of Literature
Pediatric hematological malignancy: Identification of issues involved in the road to diagnosis
Germline ERG haploinsufficiency defines a new syndrome with cytopenia and hematological malignancy predisposition
Author Correction: Differentiating central nervous system infection from disease infiltration in hematological malignancy
Targeting TIM-3 for hematological malignancy: latest updates from the 2022 ASH annual meeting